This product is an immunomodulatory drug. It has the function of regulating and enhancing the cellular immune function of the human body and can promote the maturation of T-lymphocytes.

Pharmacodynamics: This product is an immunomodulatory drug. It has the function of regulating and enhancing the cellular immune function of the human body and can promote the maturation of T-lymphocytes.

Rifampicin is a semi-synthetic broad-spectrum antibacterial drug of the rifamycin class, which has antibacterial activity against a variety of pathogenic microorganisms. The drug has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells. It has a good antibacterial effect on aerobic Gram-positive bacteria, including enzyme-producing strains of Staphylococcus aureus and methicillin-resistant strains, Streptococcus pneumoniae, other Streptococcus, Enterococcus, Listeria, Bacillus anthracis, Clostridium perfringens, Corynebacterium diphtheriae, anaerobic cocci, etc. It also has a high degree of antibacterial activity against aerobic Gram-negative bacteria such as Neisseria meningitidis, Haemophilus influenzae, and Neisseria gonorrhoeae. Rifampicin also has a good effect on Legionella, and has an inhibitory effect on pathogens such as Chlamydia trachomatis, lymphogranuloma venereum, and psittacosis.

It promotes functional recovery of central nervous system damage caused by various reasons, promotes neural reconstruction (including the survival of nerve cells, axon growth and synaptic growth), has a protective effect on secondary neurodegeneration after injury, has a positive effect on cerebral hemodynamic parameters and brain edema caused by injury, reduces nerve cell edema by improving the activity of cell membrane enzymes, and can improve behavioral disorders caused by Parkinson's disease.

It promotes brain metabolism and improves brain circulation by reducing cerebrovascular resistance and increasing cerebral blood flow. In addition, it can enhance the function of the ascending activation system of the brainstem reticular formation, enhance the function of the pyramidal system, and improve motor paralysis, so it has a certain effect on promoting the recovery of brain function and awakening.

It can promote the functional recovery of central nervous system damage caused by various reasons, protect secondary neurodegeneration after injury, have a positive effect on cerebral hemodynamic parameters and brain edema caused by injury, and can reduce nerve cell edema by improving the activity of cell membrane enzymes. Animal experiments show that monosialotetrahexosylganglioside sodium can improve behavioral disorders caused by Parkinson's disease. The mechanism of action is to promote neuroplasticity (including the survival of nerve cells, axon growth and synaptic growth).